Our Work – Broadstreet HEOR

Case Studies

Hypertension-in-Canada

Hypertension in Canada

Canadian Pharmacists Association

Network Meta Analysis

Network Meta Analysis

Visualizing COVID-19

Visualizing COVID-19

Canadian and US regions

Infographic: Biologic treatments for severe asthma

Publications

1 April 2021

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine

22 February 2025

Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC

1 September 2025

Costs of obesity, obesity-related complications, and weight loss in the United States: A systematic literature review

1 January 2025

US general population food allergy treatment preferences: a discrete choice experiment

22 April 2024

Development and Validation of SCACOMS, a Composite Scale for Assessing Disease Progression and Treatment Effects in Spinocerebellar Ataxia

8 October 2025

"Are You Just Looking to 'Survive'?": A Qualitative Study of Importance of Oncology Endpoints Beyond Overall Survival in Early-Stage Cancer

8 July 2024

Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis

9 November 2025

The EQ-5D and Health Utilities Index for assessing health-related quality-of-life impact in Duchenne muscular dystrophy: Evaluating the relevance and interpretation of descriptive systems from patient and caregiver perspectives

23 April 2021

The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era a systematic literature review

27 December 2020

Comprehensive genomic profiling for non-small-cell lung cancer health and budget impact

29 January 2025

Longitudinal Outcomes Among Patients With Duchenne Muscular Dystrophy: A Canadian Retrospective Population-Based Study

30 September 2024

Cost burden of cirrhosis and liver disease progression in metabolic dysfunction-associated steatohepatitis: A US cohort study

10 November 2020

A US cost minimization model comparing ravulizumab versus eculizumab for the treatment of atypical hemolytic uremic syndrome

6 December 2019

Characterizing health state utilities associated with Duchenne muscular dystrophy a systematic review

1 April 2024

Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK

29 January 2025

Longitudinal Outcomes Among Patients With Duchenne Muscular Dystrophy: A Canadian Retrospective Population-Based Study

Posters

MDA Virtual Congress 2021

Virtual ISPOR Europe 2020

We love what we do. Let’s connect